Can tinkering around the edges actually make this stock more attractive? Starboard Value, the activist investing group that's making waves thanks to its new $1 billion stake in Pfizer, now also has a position in the consumer healthcare business Kenvue (KVUE -0.44%). The group will seek to engage with management and propose changes to the company's operations with the aim of unlocking better returns for shareholders than the stock's 10.5% loss since its spinoff from Johnson & Johnson in 2023. The activist's ...

Ken Griffin's Citadel just added 18 million shares of an under-the-radar consumer health stock.Ken Griffin is a billionaire hedge fund manager and serves as CEO to Citadel Advisors. According to Citadel's most recent 13F filing, the firm bought 18,736,591 shares of Kenvue (KVUE -1.44%) stock during the second quarter -- increasing its position by 5,848%.Below, I'm going to break down why now could be a lucrative time to scoop up shares of Kenvue. More importantly, I'll assess the company's full picture and ...

An activist investor is taking a stake in Kenvue stock. Companies that pass along profits to shareholders through dividends can be great for generating passive income. But the stock prices of income-focused companies don't always keep pace with a growth-fueled stock market rally. However, that hasn't been the case for Kenvue (KVUE -1.44%), at least not lately, with the stock up big in just a few months. Here's what's driving the maker of Band-Aid and other products higher, and whether you should buy the div ...

Business: Kenvue is a consumer health company. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Self Care product categories include pain care; cough cold allergy; and "other self care." The Skin Health and Beauty segment's product categories include face and body care and hair, sun and others. The Essential Health segment's product categories include oral care, baby care and other essential health. Its differentiated portfolio of brands includes Tylenol, ...

The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.Shares of Kenvue (KVUE 0.92%) got a nice bounce on Monday, Oct. 21, thanks to Starboard Value. The activist investor recently pushed the stock up by announcing a stake in the consumer goods giant that's behind popular brands such as Tylenol and Listerine.Despite the recent bump, Kenvue stock has fallen by about 15% since it was spun off from Johnson & Johnson last May. The loss is extra upsetting b ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...

Key TakeawaysActivist investor Starboard Value reportedly has taken a large stake in consumer health care products maker Kenvue.The Wall Street Journal and Reuters say it's unclear how big the investment is, although the Journal says it's a "sizable stake."Starboard founder and CEO Jeff Smith is expected to discuss the hedge fund's plans for Kenvue at an investor conference tomorrow. Shares of Kenvue (KVUE) took off Monday morning on indications activist investor Starboard Value has taken a large stake in t ...

Kenvue CEO Thibaut Mongon at the New York Stock Exchange for its initial public offering, May 4, 2023.Activist investor Starboard Value has a large stake in Kenvue, which spun out of Johnson & Johnson in mid-2023, according to people familiar with the matter.The activist is looking for the company to improve its share price, said the people, who requested anonymity to discuss private information freely. CNBC could not learn size of the stake nor Starboard's specific plans. Starboard's Jeff Smith is expected ...

Target, PepsiCo, and Kenvue have high yields and inexpensive valuations. The stock market can be an excellent way to compound wealth over time. But the way an investor goes about growing their hard-earned savings can vary based on investment objectives, risk tolerance, interests, and myriad other factors. Generating passive income from dividend stocks is a way to supplement income in retirement or simply help with financial planning. Dividends can also be useful because they provide income without having to ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Kenvue (KVUE) , which belongs to the Zacks Consumer Products - Staples industry, could be a great candidate to consider. When looking at the last two reports, this consumer health company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 13.14%, on average, in the last two quarters. For the most recent q ...